Showing results (361-370 of 670) with videos related to
Sort By:
Pageof 67
International Journal of Hematology|December 4, 2022
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapyChia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 10, 2017
Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute LeukemiaChen-Hua Yan, Qi-Fa Liu, De-Pei Wu, et al.Plos One|November 27, 2013
Proteinuria independently predicts unfavorable outcome of ischemic stroke patients receiving intravenous thrombolysisChih-Hao Chen, Sung-Chun Tang, Li-Kai Tsai, et al.The Journal of Infectious Diseases|November 13, 2014
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapyCheng-Chao Liang, Chen-Hua Liu, Chen-Shuan Chung, et al.Journal of Viral Hepatitis|January 26, 2020
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairmentChen-Hua Liu, Sheng-Shun Yang, Cheng-Yuan Peng, et al.Cell Reports|June 17, 2014
A conditional system to specifically link disruption of protein-coding function with reporter expression in miceShin-Heng Chiou, Caroline Kim-Kiselak, Viviana I Risca, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneouslyHuei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.The Journal of Infectious Diseases|January 5, 2018
Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir TherapyTung-Hung Su, Hung-Chih Yang, Tai-Chung Tseng, et al.Hepatology International|March 20, 2015
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infectionHuei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 3, 2024
Distinct Immune Homeostasis Remodeling Patterns after HLA-Matched and Haploidentical TransplantationHuidong Guo, Liping Guo, Bixia Wang, et al.Pageof 67